Expression of protease-activated receptors (PARs) in OLN-93 oligodendroglial cells and mechanism of PAR-1-induced calcium signaling

Neuroscience

Volumn 126, Issue 1, 2004, Pages 69-82

  Wang, Y ^a   Richter Landsberg, C ^b   Reiser, G ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b UNIVERSITY OF OLDENBURG   (Germany)

Author keywords

2 ,3 cyclic nucleotide 3 phosphodiesterase; activating peptide; AP; base pair; bp; calcium signaling; cathepsin G; CNP; DMEM; Dulbecco's Modified Eagle medium; GAPDH; protease activated receptors; thrombin; trypsin

Indexed keywords

2 AMINO 4 PHOSPHONOBUTYRIC ACID; CALCIUM; CATHEPSIN G; GUANINE NUCLEOTIDE BINDING PROTEIN; PERTUSSIS TOXIN; PHOSPHOLIPASE C INHIBITOR; PROTEINASE ACTIVATED RECEPTOR; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2; PROTEINASE ACTIVATED RECEPTOR 3; PROTEINASE ACTIVATED RECEPTOR 4; THROMBIN; TRYPSIN;

ANIMAL CELL; ARTICLE; BRAIN TISSUE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL LINE; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; IMAGING; IMMUNOHISTOCHEMISTRY; NONHUMAN; NUCLEOTIDE SEQUENCE; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; RECEPTOR AFFINITY; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CALCIUM SIGNALING; CELL LINE, TRANSFORMED; ENDOPEPTIDASES; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; LIGANDS; OLIGODENDROGLIA; RATS; RECEPTOR, PAR-1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 2342450576     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2004.03.024     Document Type: Article

References (54)

1. Asokananthan N., Graham P.T., Fink J., Knight D.A., Bakker A.J., McWilliam A.S., Thompson P.J., Stewart G.A. Activation of protease-activated receptor (PAR)-1, PAR-2, and PAR-4 stimulates IL-6, IL-8, and prostaglandin E2 release from human respiratory epithelial cells. J Immunol. 168:2002;3577-3585
2. 2+ signaling in human airway smooth muscle cells. J Appl Physiol. 91:2001;995-1003
3. Boven L.A., Vergnolle N., Henry S.D., Silva C., Imai Y., Holden J., Warren K., Hollenberg M.D., Power C. Up-regulation of proteinase-activated receptor 1 expression in astrocytes during HIV encephalitis. J Immunol. 170:2003;2638-2646
4. Carreno-Muller E., Herrera A.J., de Pablos R.M., Tomas-Camardiel M., Venero J.L., Cano J., Machado A. Thrombin induces in vivo degeneration of nigral dopaminergic neurones along with the activation of microglia. J Neurochem. 84:2003;1201-1214
5. Cirino G., Cicala C., Bucci M.R., Sorrentino L., Maraganore J.M., Stone S.R. Thrombin functions as an inflammatory mediator through activation of its receptor. J Exp Med. 183:1996;821-827
6. Cole K., Kohn E. Calcium-mediated signal transduction Biology, biochemistry, and therapy. Cancer Metastasis Rev. 13:1994;31-44
7. Dihanich M., Kaser M., Reinhard E., Cunningham D., Monard D. Prothrombin mRNA is expressed by cells of the nervous system. Neuron. 6:1991;575-581
8. Du Y., Dreyfus C.F. Oligodendrocytes as providers of growth factors. J Neurosci Res. 68:2002;647-654
9. Feng D.M., Veber D.F., Connolly T.M., Condra C., Tang M.J., Nutt R.F. Development of a potent thrombin receptor ligand. J Med Chem. 38:1995;4125-4130
10. Fiorucci S., Distrutti E. Role of PAR2 in pain and inflammation. Trends Pharmacol Sci. 23:2002;153-155
11. Gorath M., Stahnke T., Mronga T., Goldbaum O., Richter-Landsberg C. Developmental changes of tau protein and mRNA in cultured rat brain oligodendrocytes. Glia. 36:2001;89-101
12. Ishihara H., Connolly A.J., Zeng D., Kahn M.L., Zheng Y.W., Timmons C., Tram T., Coughlin S.R. Protease-activated receptor 3 is a second thrombin receptor in humans. Nature. 386:1997;502-506
13. Junge C.E., Sugawara T., Mannaioni G., Alagarsamy S., Conn P.J., Brat D.J., Chan P.H., Traynelis S.F. The contribution of protease-activated receptor 1 to neuronal damage caused by transient focal cerebral ischemia. Proc Natl Acad Sci USA. 100:2003;13019-13024
14. Kahn M.L., Hammes S.R., Botka C., Coughlin S.R. Gene and locus structure and chromosomal localization of the protease-activated receptor gene family. J Biol Chem. 273:1998;23290-23296
15. LaRosa C.A., Rohrer M.J., Benoit S.E., Rodino L.J., Barnard M.R., Michelson A.D. Human neutrophil cathepsin G is a potent platelet activator. J Vasc Surg. 19:1994;306-318
16. Lassmann H. Neuropathology in multiple sclerosis New concepts. Mult Scler. 4:1998;93-98
17. Levine J.M., Reynolds R., Fawcett J.W. The oligodendrocyte precursor cell in health and disease. Trends Neurosci. 24:2001;39-47
18. Macfarlane S.R., Seatter M.J., Kanke T., Hunter G.D., Plevin R. Proteinase-activated receptors. Pharmacol Rev. 53:2001;245-282
19. 2+ rise in human platelets induced by polymorphonuclear-leucocyte- derived cathepsin G. Biochem J. 288:1992;741-745
20. Molino M., Blanchard N., Belmonte E., Tarver A.P., Abrams C., Hoxie J.A., Cerletti C., Brass L.F. Proteolysis of the human platelet and endothelial cell thrombin receptor by neutrophil-derived cathepsin G. J Biol Chem. 270:1995;11168-11175
21. Moller T., Hanisch U.K., Ransom B.R. Thrombin-induced activation of cultured rodent microglia. J Neurochem. 75:2000;1539-1547
22. Moore T.M., Chetham P.M., Kelly J.J., Stevens T. Signal transduction and regulation of lung endothelial cell permeability Interaction between calcium and camp. Am J Physiol. 275:1998;L203-L222
23. Muraro P.A., Kalbus M., Afshar G., McFarland H.F., Martin R. T cell response to 2′, 3′-cyclic nucleotide 3′-phosphodiesterase (CNPase) in multiple sclerosis patients. J Neuroimmunol. 130:2002;233-242
24. Nakanishi-Matsui M., Zheng Y.W., Sulciner D.J., Weiss E.J., Ludeman M.J., Coughlin S.R. PAR3 is a cofactor for PAR4 activation by thrombin. Nature. 404:2000;609-613
25. Nishikawa H., Kawabata A., Kuroda R., Nishida M., Kawai K. Characterization of protease-activated receptors in rat peritoneal mast cells. Jpn J Pharmacol. 82:2000;74-77
26. Owen W.G. PAR-3 is a low-affinity substrate, high affinity effector of thrombin. Biochem Biophys Res Commun. 305:2003;166-168
27. Pasti L., Volterra A., Pozzan T., Carmignoto G. Intracellular calcium oscillations in astrocytes A highly plastic, bidirectional form of communication between neurons and astrocytes in situ. J Neurosci. 17:1997;7817-7830
28. Polanowska J., Krokoszynska I., Czapinska H., Watorek W., Dadlez M., Otlewski J. Specificity of human cathepsin G. Biochim Biophys Acta. 1386:1998;189-198
29. Reiser G., Kunzelmann U., Steinhilber G., Binmöller F.J. Generation of a monoclonal antibody against the myelin protein CNP (2′, 3′-cyclic nucleotide 3′-phosphodiesterase) suitable for biochemical and for immunohistochemical investigations of CNP. Neurochem Res. 19:1994;1479-1485
30. Richter-Landsberg C., Heinrich M. OLN-93 A new permanent oligodendroglia cell line derived from primary rat brain glial cultures. J Neurosci Res. 45:1996;161-173
31. Richter-Landsberg C., Vollgraf U. Mode of cell injury and death after hydrogen peroxide exposure in cultured oligodendroglia cells. Exp Cell Res. 244:1998;218-229
32. Riek-Burchardt M., Striggow F., Henrich-Noack P., Reiser G., Reymann K.G. Increase of prothrombin-mRNA after global cerebral ischemia in rats, with constant expression of protease nexin-1 and protease-activated receptors. Neurosci Lett. 329:2002;181-184
33. Sambrano G.R., Huang W., Faruqi T., Mahrus S., Craik C., Coughlin S.R. Cathepsin G activates protease-activated receptor-4 in human platelets. J Biol Chem. 275:2000;6819-6823
34. Seeliger S., Derian C.K., Vergnolle N., Bunnett N.W., Nawroth R., Schmelz M., Von Der Weid P.Y., Buddenkotte J., Sunderkotter C., Metze D., Andrade-Gordon P., Harms E., Vestweber D., Luger T.A., Steinhoff M. Proinflammatory role of proteinase-activated receptor-2 in humans and mice during cutaneous inflammation in vivo. FASEB J. 17:2003;1871-1885
35. Selak M.A. Cathepsin G and thrombin Evidence for two different platelet receptors. Biochem J. 297:1994;269-275
36. 2+ mobilization, and apoptosis. J Neurobiol. 48:2001;87-100
37. Striggow F., Riek M., Breder J., Henrich-Noack P., Reymann K.G., Reiser G. The protease thrombin is an endogenous mediator of hippocampal neuroprotection against ischemia at low concentrations but causes degeneration at high concentrations. Proc Natl Acad Sci USA. 97:2000;2264-2269
38. Strukova S.M. Thrombin as a regulator of inflammation and reparative processes in tissues. Biochemistry (Mosc). 66:2001;8-18
39. Suo Z., Wu M., Ameenuddin S., Anderson H.E., Zoloty J.E., Citron B.A., Andrade-Gordon P., Festoff B.W. Participation of protease-activated receptor-1 in thrombin-induced microglial activation. J Neurochem. 80:2002;655-666
40. Totani L., Piccoli A., Pellegrini G., Di Santo A., Lorenzet R. Polymorphonuclear leukocytes enhance release of growth factors by cultured endothelial cells. Arterioscler Thromb. 14:1994;125-132
41. i-inducing protease-activated receptors (PAR-1 and PAR-2) in rat astrocytes and C6 glioma cells. Neuroscience. 86:1998;597-609
42. Ubl J.J., Grishina Z.V., Sukhomlin T.K., Welte T., Sedehizade F., Reiser G. Human bronchial epithelial cells express PAR-2 with different sensitivity to thermolysin. Am J Physiol Lung Cell Mol Physiol. 282:2002;L1339-L1348
43. Vela J.M., Gonzalez B., Castellano B. Understanding glial abnormalities associated with myelin deficiency in the jimpy mutant mouse. Brain Res Brain Res Rev. 26:1998;29-42
44. Vergnolle N., Hollenberg M.D., Sharkey K.A., Wallace J.L. Characterization of the inflammatory response to proteinase-activated receptor-2 (PAR2)-activating peptides in the rat paw. Br J Pharmacol. 127:1999;1083-1090
45. Vergnolle N., Hollenberg M.D., Wallace J.L. Pro- and anti-inflammatory actions of thrombin A distinct role for proteinase-activated receptor-1 (par1). Br J Pharmacol. 126:1999;1262-1268
46. Vergnolle N., Wallace J.L., Bunnett N.W., Hollenberg M.D. Protease-activated receptors in inflammation, neuronal signaling and pain. Trends Pharmacol Sci. 22:2001;146-152
47. Walker E.M., Bispham J.R., Hill S.J. Nonselective effects of the putative phospholipase C inhibitor, U73122, on adenosine A1 receptor-mediated signal transduction events in Chinese hamster ovary cells. Biochem Pharmacol. 56:1998;1455-1462
48. Wang H., Ubl J.J., Reiser G. Four subtypes of protease-activated receptors, co-expressed in rat astrocytes, evoke different physiological signaling. Glia. 37:2002;53-63
49. Wang H., Ubl J.J., Stricker R., Reiser G. Thrombin (PAR-1)-induced proliferation in astrocytes via MAPK involves multiple signaling pathways. Am J Physiol Cell Physiol. 283:2002;C1351-C1364
50. Wang H., Reiser G. Thrombin signaling in the brain The role of protease-activated receptors. Biol Chem. 384:2003;193-202
51. Weksler B.B., Jaffe E.A., Brower M.S., Cole O.F. Human leukocyte cathepsin G and elastase specifically suppress thrombin-induced prostacyclin production in human endothelial cells. Blood. 74:1989;1627-1634
52. Xi G., Reiser G., Keep R.F. The role of thrombin and thrombin receptors in ischemic, hemorrhagic and traumatic brain injury Deleterious or protective? J Neurochem. 84:2003;3-9
53. Xu W.F., Andersen H., Whitmore T.E., Presnell S.R., Yee D.P., Ching A., Gilbert T., Davie E.W., Foster D.C. Cloning and characterization of human protease-activated receptor 4. Proc Natl Acad Sci USA. 95:1998;6642-6646
54. Zhao J., Li L., Wu C., He R.Q. Hydrolysis of fibrinogen and plasminogen by immobilized earthworm fibrinolytic enzyme II from Eisenia fetida. Int J Biol Macromol. 32:2003;165-171